Direxion Daily S&P Biotech Bear 3X ETF
LABD
6 hedge funds and large institutions have $1.45M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2016 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 0 closing their positions.
62% more call options, than puts
Call options by funds: $13.5M | Put options by funds: $8.34M
50% more funds holding
Funds holding: 4 → 6 (+2)
0% less ownership
Funds ownership: 0.01% → 0% (-0%)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
69% less capital invested
Capital invested by funds: $4.67M → $1.45M (-$3.23M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$242K |
| 2 |
Simplex Trading
Chicago,
Illinois
|
+$242K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$80.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTUS
Flow Traders U.S.
New York
|
-$1.77M |
| 2 |
Jane Street
New York
|
-$564K |
| 3 |
CG
Cutler Group
San Francisco,
California
|
-$161K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $627K | -$564K | -7 | -44% |
|
|
2
Simplex Trading
Chicago,
Illinois
| $300K | +$242K | +3 | +300% |
|
|
3
Morgan Stanley
New York
| $243K | +$242K | +3 | New |
|
|
FTUS
4
Flow Traders U.S.
New York
| $122K | -$1.77M | -22 | -92% |
|
|
CG
5
Cutler Group
San Francisco,
California
| $95K | -$161K | -2 | -67% |
|
|
6
UBS Group
Zurich,
Switzerland
| $60K | +$80.6K | +1 | New |
|
LABD Hedge Fund Activity: Q2 2016 in Review
6 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) for Q2 2016, worth a combined $1.45M — down 69% from $4.67M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new LABD positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 3 trimmed.
The largest buyer was Morgan Stanley, opening a new position worth an estimated $242K. The largest seller was Flow Traders U.S., cutting an estimated $1.77M.
- 6 institutional investors held Direxion Daily S&P Biotech Bear 3X ETF (LABD) as of Q2 2016, up from 4 in Q1 2016.
- Funds reported $1.45M of Direxion Daily S&P Biotech Bear 3X ETF stock for Q2 2016, down 69% quarter-over-quarter.
- 2 funds opened new Direxion Daily S&P Biotech Bear 3X ETF positions in Q2 2016 and 0 closed out, a net change of +2 holders.
- The largest Direxion Daily S&P Biotech Bear 3X ETF buyer in Q2 2016 was Morgan Stanley, an estimated $242K added.
- The largest Direxion Daily S&P Biotech Bear 3X ETF seller in Q2 2016 was Flow Traders U.S., an estimated $1.77M sold.
Based on aggregated 13F filings for Q2 2016.